Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSIW) Return on Sales (2022 - 2025)

TriSalus Life Sciences' Return on Sales history spans 4 years, with the latest figure at 0.74% for Q4 2025.

  • For Q4 2025, Return on Sales rose 48.0% year-over-year to 0.74%; the TTM value through Dec 2025 reached 0.87%, up 15.0%, while the annual FY2025 figure was 0.87%, 15.0% up from the prior year.
  • Return on Sales reached 0.74% in Q4 2025 per TLSIW's latest filing, up from 0.93% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.27% in Q3 2023 to a low of 6.99% in Q4 2022.
  • Average Return on Sales over 4 years is 2.08%, with a median of 1.18% recorded in 2024.
  • Peak YoY movement for Return on Sales: soared 501bps in 2024, then plummeted -61bps in 2025.
  • A 4-year view of Return on Sales shows it stood at 6.99% in 2022, then rose by 11bps to 6.23% in 2023, then skyrocketed by 80bps to 1.22% in 2024, then surged by 40bps to 0.74% in 2025.
  • Per Business Quant, the three most recent readings for TLSIW's Return on Sales are 0.74% (Q4 2025), 0.93% (Q3 2025), and 0.74% (Q2 2025).